Yearly Archives: 2025

We want to hear community pharmacy owners’ opinions on the future direction of the Community Pharmacy Contractual Framework (CPCF) to help shape negotiating priorities for 2026/27. Ahead of CPCF 2026/27 negotiations, our summer survey aims to gather views on potential funding allocations, service priorities and regulatory asks. The questions have been informed by discussions at [...]

The post Future CPCF: What’s most important to you? appeared first on Community Pharmacy England.

Opinions from pharmacy owners and LPCs across the country are being compiled, alongside inputs from national pharmacy organisations and results from ongoing sector polling, to inform Community Pharmacy England Committee discussions on negotiating priorities for 2026/27. The Committee will consider all inputs, alongside Community Pharmacy England’s own analysis, to inform positioning and objectives for the [...]

The post Sector workshop findings to inform Committee discussions appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the following July 2025 concessionary prices: Drug Pack size Previous price concession  for July 2025 New price concession for July 2025 Fexofenadine 180mg tablets 30 £2.31 £4.10 Pioglitazone 45mg tablets 28 £25.25 [...]

The post Improved price concessions for July 2025 appeared first on Community Pharmacy England.

NHS England previously announced the launch of a new community pharmacy Point of Care (PoC) IT Supplier Contractual Framework, which will allow pharmacy owners to choose which PoC system they use to make their clinical records for the Flu and COVID-19 vaccination services during the Autumn/Winter 2025/26 campaign. IT suppliers listed on the new framework will be assured by NHS [...]

The post Getting ready for the Flu Vaccination Service: Have you chosen your IT system yet? appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd Drug alert number: EL(25)A/39 Date issued: 07 August 2025 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate Zydus Pharmaceuticals UK [...]

The post Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd appeared first on Community Pharmacy England.